Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Expanded access to maraviroc for HIV-1 infection
2011-004435-31Phase 3Completed
- Sponsor
- ViiV Healthcare
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of maraviroc in human immunodeficiency virus infection (HIV), sponsored by ViiV Healthcare. Started Jan 2012; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2011-004435-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004435-31.